Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | DYP688 |
Synonyms | |
Therapy Description |
DYP688 inhibits GNAQ/GNA11, leading to decreased downstream signaling and potentially resulting in reduced cell proliferation in GNAQ/GNA11-overexpressing and/or mutant tumors (NCI Thesaurus). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
DYP688 | DYP 688|DYP-688 | DYP688 inhibits GNAQ/GNA11, leading to decreased downstream signaling and potentially resulting in reduced cell proliferation in GNAQ/GNA11-overexpressing and/or mutant tumors (NCI Thesaurus). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05415072 | Phase Ib/II | DYP688 | A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas | Recruiting | USA | NLD | FRA | ESP | DEU | CHE | AUS | 0 |